Crohn's fistula: Current concepts in management

Gastroenterology

Volumn 124, Issue 6, 2003, Pages 1629-1635

  Present, Daniel H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CD 571; CIPROFLOXACIN; CORTICOSTEROID; CYCLOSPORIN A; DISULFIRAM; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; PLACEBO; SALAZOSULFAPYRIDINE; TACROLIMUS; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ANUS FISTULA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; CROSSOVER PROCEDURE; DELAYED HYPERSENSITIVITY; DOUBLE BLIND PROCEDURE; FATIGUE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE FISTULA; LIVER FIBROSIS; MAJOR CLINICAL STUDY; META ANALYSIS; MULTICENTER STUDY; NAUSEA; NEPHROTOXICITY; PANCREATITIS; PERIPHERAL NEUROPATHY; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; REVIEW;

EID: 0037855695     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00392-5     Document Type: Review

References (40)

1. Glotzer DJ. Surgical therapy for Crohn's disease. Gastroenterol Clin North Am 1995;24:577-596.
2. Allan A, Keighley RB. Management of perianal disease. World J Surg 1988;12:198-202.
3. Givel JC, Hawker P, Allan R, Alexander-Williams J. Entero-enteric fistula complicating Crohn's disease. J Clin Gastroenterol 1983;5:321-323.
4. Schwartz DA, Loftus EV Jr, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of fistulizing Crohn's disease in Olmstead County, Minnesota. Gastroenterology 2002;122:875-880.
5. Hellers G, Bergstrand O, Ewerth S, Holmstrom B. Occurrence in outcome after primary treatment of anal fistulae in Crohn's disease. Gut 1980;21:525-527.
6. D'Haens G. Medical management of internal fistulae in Crohn's disease. Inflamm Bowel Dis 2006;6:244-245.
7. Aeberhard P, Berchtold W, Riedtmann HJ, Stadelmann G. Surgical recurrence of perforating and non-perforating Crohn's disease - a study of surgically treated patients. Dis Colon Rectum 1996;39:80-87.
8. Parks AG, Gordon PH, Hardcastle JD. A classification of fistulain-ano. Br J Surg 1976;63:1-12.
9. Schwartz DA, Pemberton JH, Sandborn WJ. Diagnosis and treatment of perianal fistulas in Crohn disease. Ann Intern Med 2001;135:906-918.
10. Schwartz DA, Wiersema MJ, Dudiak KM, Fletcher JG, Clain JE, Tremaine WJ, Zinsmeister AR, Norton ID, Baardman LA, Devine RM, Wolff BG, Young-Fadok TM, Dehl NN, Pemberton JU, Sandborn WJ. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology 2001;121:1064-1072.
11. Hamalainen K-PJ, Sainio AP. Incidence of fistulas after drainage of acute anorectal abscesses. Dis Colon Rectum 1998;41:1357-1362.
12. Makowiecs JO, Jehle BC, Becker HD, Starlinger M. Perianal abscess in Crohn's disease. Dis Colon Rectum 1997;40:443-450.
13. Sohn N. Selected summaries. Inflamm Bowel Dis 1998;4:257.
14. Williams JG, Rothenberger DA, Nemer FD, Goldberg SM. Fistulain-ano in Crohn's disease with results of aggressive surgical treatment. Dis Colon Rectum 1991;34:378-384.
15. Present DH. How to do without steroids in inflammatory bowel disease. Inflamm Bowel Dis 2000;6:48-57.
16. Present DH. Urinary tract fistulas in Crohn's disease: surgery versus medical therapy. Am J Gastroenterol 2002;97:2165-2167.
17. Ursing B, Kamme C. Metronidazole for Crohn's disease. Lancet 1975;1:775-777.
18. Sutherland L, Singleton J, Sessions J, Hanauer S, Krawitt E, Rakin G, Summers R, Mekhjian N, Greenberger N, Kelly M, Levine J, Thomson A, Alpert E, Prokipchu K. Double blind placebo control trial of metronidazole in Crohn's disease. Gut 1991;32:1071-1075.
19. Bernstein LH, Frank MS, Brandt U, Boley SJ. Healing of perineal Crohn's disease with metronidazole. Gastroenterology 1987;79:357-365.
20. Colombel JF, Lemann M, Cassagnou M, Scuhnik Y, Duclos B, Notteghem B, and the GETAID. A control trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Am J Gastroenterol 1999;94:674-678.
21. Turunen UM, Farkkila M, Valtone N. Long-term outcome of ciprofloxacin in the treatment of severe perianal or fistulous Crohn's disease. Gastroenterology 1993;104A:793 (abstr).
22. Solomon MJ. Combination of ciprofloxacin and metronidazole in severe perianal Crohn's disease. Can J Gastroenterol 1993;7:571-573.
23. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DG, Pasternack BS. Treatment of Crohn's disease with 6 Mercaptopurine. A long term randomized double blind study. N Engl J Med 1980;302:981-987.
24. Korelitz BI, Present DH. The favorable effects of 6 mercaptopurine in the fistulous Crohn's disease. Dig Dis Sci 1985;30:58-64.
25. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6 mercaptopurine in Crohn's disease - a meta-analysis. Ann Intern Med 1995;123:132-142.
26. Muhadevan U, Marion J, Present DH. The price of methotrexate in the treatment of refractory Crohn's disease. Gastroenterology 1997;112A:1031 (abstr).
27. Present DH, Lichtiger S. Efficacy of cyclosporin in the treatment of fistula of Crohn's disease. Dig Dis Sci 1994;39:374-380.
28. Lowery PW, Weaver AL, Tremaine WJ, et al. Combination therapy with oral Tacrolimus (FK506) and Azathioprine with 6 Mercaptopurine for treatment refractory Crohn's disease perianal fistula. Inflamm Bowel Dis 1999;5:239-245.
29. Sandborn WJ. Preliminary report on the use of oral Tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease. Am J Gastroenterol 1997;92:876-879.
30. Sandborn WJ, Present DH, Isaacs KL, Wolf DR, Greenberg E, Hanauer SB, Feacan BG, Johnson T, Galanka J, Martin C, Sandier RS. Tacrolimus (FK506) for the treatment of perianal and entero-cutaneous fistulas in patients with Crohn's disease: a randomized double blind placebo control trial. Gastroenterology 2003;124: (in press).
31. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, Van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, Van Deventer SJI. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999;340:1398-1405.
32. Sandborn WJ, Hanauer SD. Infliximab in the treatment of Crohn's disease. A user's guide for clinicians. Am J Gastroenterol 2002;97:2962-2972.
33. Sands B, Vandeventer B, Bernstein C, et al. Long-term treatment of fistulizing Crohn's disease: response to Infliximab in the Accent II trial through 54 weeks. Gastroenterology 2002;122:A8I (abstr).
34. Sandborn WJ, Feagan SC, Hanauer SB, Present DH, Sutherland LR, Komm MK, Wolf DC, Baker JP, Hawkey C, Archamboult N, Bernstein CN, Novak C, Targan SR. An engineered human antibody TΔTNF(CDP 571) for active Crohn's disease: a randomized, double blind, placebo controlled trial. Gastroenterology 2001;120:1330-1338.
35. Ochsenkuhn T, Goke B, Sackmann M. Combining Infliximab with 6 Mercaptopurine/Azathioprine for fistula therapy in Crohn's disease. Am J Gastroenterol 2002;97:2022-2025.
36. Wheeler C, Marion JF, Present DH. Medical therapy, not surgery, is the appropriate first line treatment of Crohn's enterovesical fistula (abstr). Gastroenterology 1998;114A:1113.
37. Sonoda T, Haull T, Piedmonte MR, Fazi V. Outcomes of primary repair of anorectal and rectovaginal fistulas using the endorectal advancement flap. Dis Colon Rectum 2002;45:1622-1628.
38. Ky A, Sohn N, Weinstein MA, Conners Jr AF. Carcinoma arising in anorectal fistulas of Crohn's disease. Dis Colon Rectum 1998;41:992-996.
39. Arsenau KO, Cohn SM, Cominelli F, Korelitz BI. Cost-utility as initial medical management for Crohn's disease perianal fistulae. Gastroenterology 2001;120:1640-1656.
40. Baert F, Noman M, Vermeire S, Van Assgie G, D'Haens G, Carbonez A, Rutgeerts P. Influence of immunogenicity on the long term efficacy of Infliximab in Crohn's disease. N Engl J Med 2003;348:601-608.